Cargando…
Treatment of juxtapapillary hemangioblastoma by intra-arterial (ophthalmic artery) chemotherapy with bevacizumab
PURPOSE: To report on two cases of treatment-refractory juxtapapillary hemagioblastomas that were managed with intra-arterial bevacizumab delivered via the ophthalmic artery. OBSERVATIONS: Case 1 is a 35 year-old man with juxtapapillary hemangioblastoma who continued to have progressive tractional r...
Autores principales: | Francis, Jasmine H., Slakter, Jason S., Abramson, David H., Odrich, Steven A., Gobin, Y. Pierre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6026768/ https://www.ncbi.nlm.nih.gov/pubmed/29978140 http://dx.doi.org/10.1016/j.ajoc.2018.05.007 |
Ejemplares similares
-
Intra-Arterial Chemotherapy (Ophthalmic Artery Chemosurgery) for Group D Retinoblastoma
por: Abramson, David H., et al.
Publicado: (2016) -
Total retinal detachments due to retinoblastoma: Outcomes following intra-arterial chemotherapy/ophthalmic artery chemosurgery
por: Rowlands, Megan A., et al.
Publicado: (2018) -
Choroidal infarction following ophthalmic artery chemotherapy
por: Bohm, Kelley J., et al.
Publicado: (2018) -
Intra-arterial Bevacizumab for Posterior Fossa Hemangioblastoma
por: Sokol, Zachary, et al.
Publicado: (2022) -
Combined, Sequential Intravenous and Intra-Arterial Chemotherapy (Bridge Chemotherapy) for Young Infants with Retinoblastoma
por: Gobin, Y. Pierre, et al.
Publicado: (2012)